The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
A council in Wales has had to pay more than £8,600 to end a hire contract for a Porsche its former boss used to drive.
Cold weather is again on the way for the UK. Colder conditions will spread south, bringing a mixture of sunny spells and snow showers
Siarad cymraeg McBusted? Well you will be by April! Pop band get a lesson in Welsh ahead of their Cardiff gig